Data processing: artificial intelligence – Miscellaneous
Reexamination Certificate
2001-05-02
2009-06-02
Vincent, David R (Department: 2129)
Data processing: artificial intelligence
Miscellaneous
C424S010100, C707S793000, C706S924000
Reexamination Certificate
active
07542961
ABSTRACT:
The system of the present invention for assessing and analyzing the risks of adverse effects resulting from the use of at least one substance of interest, comprises a selector for identifying at least one substance of interest; a profiler for selecting from multiple profiles related to the safety of the at least one substance of interest, using at least one filter; at least one data mining engine; and an output device for displaying the analytic results from the data mining engine. Preferably, the at least one data mining engine is selected from (1) a proportional analysis engine to assess deviations in a set of the reactions to the drug of interest; (2) a comparator to measure the reactions to the drug of interest against a user-defined backdrop, and (3) a correlator to look for correlated signal characteristics in drug/reaction/demographic information; and an output device whereby a user can receive analytic results from the selector, the proportional analysis engine, the comparator, and the correlator.
REFERENCES:
patent: 5299121 (1994-03-01), Brill et al.
patent: 5337919 (1994-08-01), Spaulding et al.
patent: 5371807 (1994-12-01), Register et al.
patent: 5495604 (1996-02-01), Harding et al.
patent: 5502576 (1996-03-01), Ramsay et al.
patent: 5583758 (1996-12-01), McIlroy et al.
patent: 5592668 (1997-01-01), Harding et al.
patent: 5594637 (1997-01-01), Eisenberg et al.
patent: 5634053 (1997-05-01), Noble et al.
patent: 5642731 (1997-07-01), Kehr
patent: 5664109 (1997-09-01), Johnson et al.
patent: 5692171 (1997-11-01), Andres
patent: 5737539 (1998-04-01), Edelson et al.
patent: 5758095 (1998-05-01), Albaum et al.
patent: 5804803 (1998-09-01), Cragun et al.
patent: 5833599 (1998-11-01), Schrier et al.
patent: 5845255 (1998-12-01), Mayaud
patent: 5860917 (1999-01-01), Comanor et al.
patent: 5864789 (1999-01-01), Lieberman et al.
patent: 5911132 (1999-06-01), Sloane
patent: 5924074 (1999-07-01), Evans
patent: 6000828 (1999-12-01), Leet
patent: 6014631 (2000-01-01), Teagarden et al.
patent: 6067524 (2000-05-01), Byerly et al.
patent: 6076083 (2000-06-01), Baker
patent: 6076088 (2000-06-01), Paik et al.
patent: 6082776 (2000-07-01), Feinberg
patent: 6108635 (2000-08-01), Herren et al.
patent: 6120443 (2000-09-01), Cohen-Laroque
patent: 6137911 (2000-10-01), Zhilyaev
patent: 6151581 (2000-11-01), Kraftson et al.
patent: 6219674 (2001-04-01), Classen
patent: 6226564 (2001-05-01), Stuart
patent: 6263329 (2001-07-01), Evans
patent: 2002/0073042 (2002-06-01), Maritzen et al.
patent: 2002/0142815 (2002-10-01), Candelore
patent: 2004/0015372 (2004-01-01), Bergman et al.
patent: 2004/0030503 (2004-02-01), Arouh et al.
patent: 10-225500 (1998-08-01), None
patent: 11-282934 (1999-10-01), None
Ng et al, “An Intelligent Agent for Web Advertisements”, International Symposium on Cooperative Database Systems for Advance Applications, Apr. 23-24, 2001.
Szarfman, Ana, M.D., Ph.D., “New Methods for Signal Detection,” Proceedings of the 15thInternational Conference on Pharmacoepidemiology, 56 pp., Aug. 28, 1999.
Karel,M. “Tasks of Food Technology in the 21st Century” FoodTechnology. vol. 54, No. 6; Jun. 2000.
Guo,J.J. et al. “Comparison and Analysis of the National Drug Code Systems Among Drug Information Databases” Drug Information Journal vol. 32. 1998.
Stead, W.W. et al. “Integration and Beyond: Linking Information from Disparate Sources and into Workflow” Journal of the American Medical Informatics Association vol. 7 No. 2. Mar./Apr. 2000.
Szarfman, Ana, M.D., Ph.D., “New Methods for Signal Detection,” Proceedings of the 15th International Conference on Pharmacoepidemiology, 56 pp., Aug. 28, 1999.
Friedman,M.A. et al. “The Safety of Newly Approved Medicines: Do Recent Market Removals Mean There Is a Problem?” Journal of teh American Medical Association (JAMA), vol. 281, No. 18, pp. 1728-1734. May 12 1999.
Omoigui,N.A. et al. “Observational versus Randomized Medical Device Testing Before and After Market Approval—The Atherectomy-versus-angioplasty Controversy” Controlled Clinical Trials 16:143-149, Elsevier Science Inc. 1995.
Multum Trusted Health Information [online], [retrieved on Aug. 22, 2002], 1 p., Retrieved from the Internet: http://www.multum.com.
Epocrates [online], Copyright 2002 [retrieved on Aug. 22, 2002], 1 p., Retrieved from the Internet: http://www.epocrates.com.
PDR.net [online], Copyright 2002 [retrieved on Aug. 22, 2002], 1 p., Retrieved from the Internet: http//www.pdr.net/HomePage—template.jsp.
“VAERS Data: Guide to Interpreting Case Report Information Obtained From the Vaccine Adverse Event Reporting System (VAERS)” [online], [retrieved on Jun. 11, 2002, 2 pp., Retrieved from the Internet: http://www.vaers.org/info.
Szarfman, Ana, M.D., Ph.D., “Application of Screening Algorithms and Computer Systems to Efficiently Signal Combinations of Drugs and Events in FDA's Spontaneous Reports” [online], Oct. 22, 2001, 2pp., Retrieved from the Internet: http://apha.confex.com/apha/129.am/techprogram/paper—32272.
“Vaccine Adverse Event Reporting System (VAERS)” [online], U.S. Department of Health and Human Services, Jul. 2001 [retrieved Jul. 2001], 12 pp., Retrieved from the Internet: http://www.vaers.org/search/README.
Andrews, Michelle, “Prescription for Disaster,”SmartMoney, pp. 124-129, May 2001.
Mootrey, Gina, et al., “Chapter 18: Surveillance for Adverse Events Following Vaccination,”VPD Surveillance Manual, 20 pp., 1999.
Szarfman, Ana, M.D., Ph.D., “New Methods for Signal Detection,”Proceedings of the 15thInternational Conference on Pharmacoepidemiology, 56 pp., Aug. 28, 1999.
DuMouchel, William, “Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System,”The American Statistician, vol. 53, No. 3., 31 pp., Apr. 1999.
“The Totally Unauthorized, Completely Repudiated, Bootlegged, Unsupported, Undocumented, Insider's Post-Pre-Alpha Guide to Multum's Lexicon,” Multum Information Services, Inc., pp. 1-49, Copyright 1997-1999, Apr. 12, 1999 (Rev. 3.d).
“Post-Marketing Surveillance for Adverse Events After Vaccination: The National Vaccine Adverse Event Reporting System (VAERS),”Medwatch, 12 pp., Nov. 1998.
“Multum Releases Web-Based MediSource Lexicon; Downloadable Drug Product and Disease Listings Database,”PR Newswire, 2 pp., Apr. 10, 1997.
Lipschutz, Seymour, Ph.D., “Theory and Problems of Linear Algebra,” Schaum's Outline Series, McGraw-Hill Book Company, 5 pp., 1968.
Anderson, T. W., “A Bibliography of Multivariate Statistical Analysis,” Oliver & Boyd, Edinburgh, 3 pp., 1972.
Darlington, Richard B., “Regression and Linear Models,” McGraw-Hill Publishing Company, 15 pp., 1990.
Press, James S. and Wilson, Sandra, “Choosing Between Logistic Regression and Discriminant Analysis,”Journal of the American Statistical Association, vol. 73, pp. 699-705, Dec. 1978.
Kosko, Bart, “Neural Networks and Fuzzy Systems—A Dynamical Systems Approach to Machine Intelligence,” Prentice Hall, Englewood Cliffs, NJ, 11 pp., 1992.
International Search Report for Application No. PCT/US02/13666, dated Jul. 16, 2002 (mailing date).
International Search Report for Application No. PCT/US02/13662, dated Jul. 15, 2002 (mailing date).
Buss Benjamin
Morrison & Foerster / LLP
Vincent David R
LandOfFree
Method and system for analyzing drug adverse effects does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and system for analyzing drug adverse effects, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and system for analyzing drug adverse effects will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4122087